THE BIOAVAILABILITY AND PHARMACOKINETICS OF ORAL AND DEPOT INTRAMUSCULAR HALOPERIDOL IN SCHIZOPHRENIC-PATIENTS

被引：49

作者：

NAYAK, RK

DOOSE, DR

NAIR, NPV

机构：

[1] DOUGLAS HOSP RES CTR,MONTREAL,QUEBEC,CANADA

[2] MCNEIL PHARMACEUT,DEPT DRUG METAB,SPRING HOUSE,PA 19477

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 1987年 / 27卷 / 02期

关键词：

D O I：

10.1002/j.1552-4604.1987.tb02175.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：144 / 150

页数：7

共 23 条

[1]

CURRY SH, 1978, LANCET, V1, P1217

[2] KINETICS OF FLUPHENAZINE AFTER FLUPHENAZINE DIHYDROCHLORIDE, ENANTHATE AND DECANOATE ADMINISTRATION TO MAN [J].

CURRY, SH ;

WHELPTON, R ;

SCHEPPER, PJD ;

VRANCKX, S ;

SCHIFF, AA .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 7 (04) :325-331

[3] INTRAMUSCULAR HALOPERIDOL DECANOATE FOR NEUROLEPTIC MAINTENANCE THERAPY - EFFICACY, DOSAGE SCHEDULE AND PLASMA-LEVELS - AN OPEN MULTI-CENTER STUDY [J].

DEBERDT, R ;

ELENS, P ;

BERGHMANS, W ;

HEYKANTS, J ;

WOESTENBORGHS, R ;

DRIESENS, F ;

REYNTJENS, A ;

VANWIJNGAARDEN, I .

ACTA PSYCHIATRICA SCANDINAVICA, 1980, 62 (04) :356-363

[4]

ERESHEFSKY L, 1984, J CLIN PSYCHIAT, V45, P50

[5]

ERESHEFSKY L, 1984, J CLIN PSYCHOPHARM, V4, P138

[6] GAS-CHROMATOGRAPHIC METHOD FOR DETERMINING HALOPERIDOL - SENSITIVE PROCEDURE FOR STUDYING SERUM CONCENTRATION AND PHARMACOKINETICS OF HALOPERIDOL IN PATIENTS [J].

FORSMAN, A ;

MARTENSSON, E ;

NYBERG, G ;

OHMAN, R .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1974, 286 (02) :113-124

[7]

HOLLAND ML, 1983, 35TH NAT M AM PHARM

[8]

ITOH H, 1984, PROG NEURO-PSYCHOPH, V8, P285

[9] SERUM LEVEL OF HALOPERIDOL AND ITS CLINICAL-SIGNIFICANCE [J].

ITOH, H ;

YAGI, G ;

OHTSUKA, N ;

IWAMURA, K ;

ICHIKAWA, K .

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY, 1980, 4 (02) :171-183

[10] MEASUREMENT OF HALOPERIDOL IN HUMAN-PLASMA USING REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].

JATLOW, PI ;

MILLER, R ;

SWIGAR, M .

JOURNAL OF CHROMATOGRAPHY, 1982, 227 (01) :233-238

← 1 2 3 →